IN2015DN03978A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN03978A IN2015DN03978A IN3978DEN2015A IN2015DN03978A IN 2015DN03978 A IN2015DN03978 A IN 2015DN03978A IN 3978DEN2015 A IN3978DEN2015 A IN 3978DEN2015A IN 2015DN03978 A IN2015DN03978 A IN 2015DN03978A
- Authority
- IN
- India
- Prior art keywords
- composition
- present
- compound
- tricyclic indole
- indole compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3978DEN2015 IN2015DN03978A (es) | 2012-11-30 | 2013-11-28 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3689DE2012 | 2012-11-30 | ||
| GBGB1300647.3A GB201300647D0 (en) | 2013-01-15 | 2013-01-15 | Crystallization |
| PCT/EP2013/074986 WO2014083113A1 (en) | 2012-11-30 | 2013-11-28 | Crystallization process of tricyclic indole derivatives |
| IN3978DEN2015 IN2015DN03978A (es) | 2012-11-30 | 2013-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03978A true IN2015DN03978A (es) | 2015-10-02 |
Family
ID=54266915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3978DEN2015 IN2015DN03978A (es) | 2012-11-30 | 2013-11-28 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10709798B2 (es) |
| EP (1) | EP2943195A1 (es) |
| JP (1) | JP6280560B2 (es) |
| KR (1) | KR20150088802A (es) |
| CN (2) | CN111362863A (es) |
| AU (1) | AU2013351152A1 (es) |
| BR (1) | BR112015012138A2 (es) |
| CA (1) | CA2892485A1 (es) |
| IN (1) | IN2015DN03978A (es) |
| MX (1) | MX2015006871A (es) |
| RU (1) | RU2015118217A (es) |
| WO (1) | WO2014083113A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2015118217A (ru) | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
| US20160144477A1 (en) * | 2014-11-21 | 2016-05-26 | Diane Scott | Coated compressive subpad for chemical mechanical polishing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177440B1 (en) * | 1996-10-30 | 2001-01-23 | Eli Lilly And Company | Substituted tricyclics |
| JP2001522884A (ja) | 1997-11-14 | 2001-11-20 | イーライ・リリー・アンド・カンパニー | アルツハイマー病の処置方法 |
| DZ2769A1 (fr) | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
| EP1423366A1 (en) | 2001-08-09 | 2004-06-02 | Eli Lilly And Company | Cyclopenta b ! indole derivatives as spla2 inhibitors |
| EP1438290B1 (en) | 2001-08-09 | 2005-12-14 | Eli Lilly And Company | Cyclohept b!indole derivatives as spla2 inhibitors |
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| ES2688574T3 (es) | 2010-03-26 | 2018-11-05 | Ge Healthcare Limited | Derivados de indol tricíclicos como ligandos de PBR |
| GB201016038D0 (en) | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
| GB201016411D0 (en) | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
| GB201021263D0 (en) | 2010-12-15 | 2011-01-26 | Ge Healthcare Ltd | Solid phase extraction method |
| US9220795B2 (en) * | 2011-09-22 | 2015-12-29 | Ge Healthcare Limited | Indole derivatives |
| RU2015118217A (ru) | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
-
2013
- 2013-11-28 RU RU2015118217A patent/RU2015118217A/ru not_active Application Discontinuation
- 2013-11-28 EP EP13796090.2A patent/EP2943195A1/en not_active Withdrawn
- 2013-11-28 KR KR1020157013974A patent/KR20150088802A/ko not_active Application Discontinuation
- 2013-11-28 CN CN202010090283.9A patent/CN111362863A/zh active Pending
- 2013-11-28 MX MX2015006871A patent/MX2015006871A/es unknown
- 2013-11-28 AU AU2013351152A patent/AU2013351152A1/en not_active Abandoned
- 2013-11-28 IN IN3978DEN2015 patent/IN2015DN03978A/en unknown
- 2013-11-28 CN CN201380062872.4A patent/CN104837489A/zh active Pending
- 2013-11-28 WO PCT/EP2013/074986 patent/WO2014083113A1/en active Application Filing
- 2013-11-28 JP JP2015544462A patent/JP6280560B2/ja active Active
- 2013-11-28 BR BR112015012138A patent/BR112015012138A2/pt not_active IP Right Cessation
- 2013-11-28 CA CA2892485A patent/CA2892485A1/en not_active Abandoned
- 2013-11-28 US US14/648,353 patent/US10709798B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150088802A (ko) | 2015-08-03 |
| RU2015118217A (ru) | 2017-01-11 |
| EP2943195A1 (en) | 2015-11-18 |
| JP2016507477A (ja) | 2016-03-10 |
| JP6280560B2 (ja) | 2018-02-14 |
| WO2014083113A1 (en) | 2014-06-05 |
| US10709798B2 (en) | 2020-07-14 |
| BR112015012138A2 (pt) | 2017-07-11 |
| MX2015006871A (es) | 2015-09-16 |
| CA2892485A1 (en) | 2014-06-05 |
| US20150335766A1 (en) | 2015-11-26 |
| CN111362863A (zh) | 2020-07-03 |
| CN104837489A (zh) | 2015-08-12 |
| AU2013351152A1 (en) | 2015-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00988A (es) | ||
| IN2012MN02591A (es) | ||
| IN2015DN01156A (es) | ||
| IN2014MN00948A (es) | ||
| MD20150091A2 (ro) | Compuşi antivirali | |
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| IN2014MN00986A (es) | ||
| IN2014MN02598A (es) | ||
| PH12015501452A1 (en) | Novel quinolone derivatives | |
| UA115558C2 (uk) | Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань | |
| IN2014MN02049A (es) | ||
| NZ743274A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
| SG190785A1 (en) | Antiviral compounds | |
| IN2014MN00987A (es) | ||
| WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| UA110943C2 (uk) | N-ацилсульфонамідні промотори апоптозу | |
| IN2015DN01119A (es) | ||
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
| GB2489382A (en) | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases | |
| MX2013004759A (es) | Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl). | |
| IN2014MN02056A (es) | ||
| IN2013DN02555A (es) |